ARTICLE | Company News
Cerep, Eli Lilly, Servier deal
June 22, 2009 7:00 AM UTC
Cerep will grant Eli Lilly access to its kinase assay platform to research undisclosed targets. The platform includes assay screening for 250 targets. Further terms were not disclosed. ...